Randi J. Hagerman

Randi J. Hagerman, M.D. is the medical director of MIND Institute at the University of California, Davis.[1][2] She works for the pediatrics apartment under the division of child development and behavior. She is an internationally recognized researcher in the field of genetics of autism spectrum disorder with special focus on genomic instability. Along with her husband Paul Hagerman, she discovered the Fragile X-associated tremor/ataxia syndrome (FXTAS), a neurological disorder that affects older male and rare female carriers of fragile X.[3][4]

Randi J. Hagerman
NationalityUnited States
Alma materStanford University
Known forFragile-X Syndrome and FXTAS
Scientific career
FieldsBehavior genetics, Autism Fragile X Syndrome, behavioral pharmacology
InstitutionsUniversity of California, Davis
Websitewww.ucdmc.ucdavis.edu/mindinstitute/ourteam/faculty/hagerman_r.html

Work

Dr. Hagerman has written over 200 peer-reviewed articles and book chapters on neurodevelopmental disorders. Some of the specific topics of her papers include repeat expansion and the genetics of neurodevelopmental disorders (e.g. Fragile-X). She also works on an editorial board to help edit the publications Journal of Developmental and Behavioral Pediatrics and Molecular Autism.

Awards
  • Jerrett Cole Award, National Fragile X Foundation, 1992
  • Bonfils-Stanton Foundation Award for Science including Medicine, 1993
  • Namesake (with Paul Hagerman), Hagerman Award for Research in FXTAS, International Association for the Study of Intellectual Deficiency, 2004
  • Lifetime Achievement Award, National Fragile X Foundation, 2008

Education[5]

Education
  • B.S., Zoology, UC Davis, Davis, California, 1971

Residency
  • Stanford University School of Medicine, Palo Alto, California, 1976-77

Fellowships
  • University of California, San Diego, La Jolla, California, 1978-80

Board Certifications

Professional Memberships[6]

Dr. Hagerman is a devote member of several organizations that seek to study child development.

References
  1. "5 Questions for Dr. Randi Hagerman: Fragile X Conditions expert". blog.sfgate.com. 30 January 2013. Retrieved 1 July 2016.
  2. Megan Brooks (7 September 2010). "Minocycline Promising in Fragile X Syndrome". medscape.com. Retrieved 1 July 2016.
  3. Hagerman, Randi J., et al. "Fragile-X–associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation." The American Journal of Human Genetics 74.5 (2004): 1051-1056.
  4. Greco, C. M., et al. "Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS)." Brain 129.1 (2006): 243-255.
  5. "Randi J. Hagerman, M.D. for UC Davis Health". health.ucdavis.edu. Retrieved 2019-03-09.
  6. "Randi J. Hagerman, M.D. for UC Davis Health". health.ucdavis.edu. Retrieved 2019-03-09.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.